More than ~50% of melanoma lesions are characterized by point mutations of BRAF (V-raf murine sarcoma viral oncogene homolog B1), and the most common mutation displayed is a valine to glutamic acid substitution (V600E) [1]. This evidence concerns the gene BRAF and melanoma.